If the rounds that Health Catalyst and Zephyr Health have put together are any indication of how the rest of the year might go for fledgling healthcare data analytics startups, we can expect to see bigger, mid-stage deals this year, and not in the places you might expect.
New analysis from research firm CB Insights found that venture funding for companies developing predictive and prescriptive data analytics for healthcare more than doubled from 2012 to 2013, while deal volume rose 40 percent. These are companies that are working with providers or payers to convert all of the data they’re collecting into insights that will hopefully guide more effective and less costly care.